1,032
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Retrospective study of risk factors for pericardial effusion after haematopoietic stem cell transplantation in children

ORCID Icon, , , , , , & show all
Article: 2245259 | Received 19 Apr 2023, Accepted 02 Aug 2023, Published online: 08 Aug 2023

References

  • Zhao Y, He R, Oerther S, et al. Cardiovascular complications in hematopoietic stem cell transplanted patients. J Pers Med. 2022;12(11):1797.
  • Tinianow A, Gay JC, Bearl DW, et al. Pericardial effusion following hematopoietic stem cell transplantation in children: incidence, risk factors, and outcomes. Pediatr Transplant. 2020;24(5):e13748.
  • Diamond M, Ruiz-Mesa C, Corrales-Medina FF, et al. Incidence and outcome of pericardial effusion in pediatric patients after hematopoietic stem cell transplant: a single-institution experience. J Pediatr Hematol Oncol. 2018;40(2):132–136.
  • Jaing TH, Chen SH, Wen YC, et al. Factors affecting survival in children with pericardial effusion after hematopoietic stem cell transplantation. Cell Transplant. 2017;26(11):1792–1797.
  • Neier M, Jin Z, Kleinman C, et al. Pericardial effusion post-SCT in pediatric recipients with signs and/or symptoms of cardiac disease. Bone Marrow Transplant. 2011;46(4):529–538.
  • Pfeiffer TM, Rotz SJ, Ryan TD, et al. Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series. Bone Marrow Transplant. 2017;52(4):630–633.
  • Khandaker MH, Espinosa RE, Nishimura RA, et al. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010;85(6):572–593.
  • Rhodes M, Lautz T, Kavanaugh-Mchugh A, et al. Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients. Bone Marrow Transplant. 2005;36(2):139–144.
  • Cox K, Punn R, Weiskopf E, et al. Pericardial effusion following hematopoietic cell transplantation in children and young adults is associated with increased risk of mortality. Biol Blood Marrow Transplant. 2017;23(7):1165–1169.
  • Versluys AB, Grotenhuis HB, Boelens MJJ, et al. Predictors and outcome of pericardial effusion after hematopoietic stem cell transplantation in children. Pediatr Cardiol. 2018;9(2):236–244.
  • Aldoss O, Gruenstein DH, Bass JL, et al. Pericardial effusion after pediatric hematopoietic cell transplant. Pediatr Transplant. 2013;17(3):294–299.
  • Chen X, Zou Q, Yin J, et al. Pericardial effusion post transplantation predicts inferior overall survival following allo-hematopoietic stem cell transplant. Bone Marrow Transplant. 2016;51(2):303–306.
  • Liu YC, Gau JP, Hong YC, et al. Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation-association with chronic GVHD in late-onset adult patients. Ann Hematol. 2012;91(12):1953–1958.
  • Norkin M, Ratanatharathorn V, Ayash L, et al. Large pericardial effusion as a complication in adults undergoing SCT. Bone Marrow Transplant. 2011;46(10):1353–1356.
  • Liu YC, Chien SH, Fan NW, et al. Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2015;169(5):737–745.
  • Kubo H, Imataki O, Fukumoto T, et al. Risk factors for and the prognostic impact of pericardial effusion after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2021;27(11):949. e1–9949.e8.
  • Johansson T, Partanen J, Saavalainen P. HLA allele-specific expression: methods, disease associations, and relevance in hematopoietic stem cell transplantation. Front Immunol. 2022;13:1007425.
  • Schoemans HM, Lee SJ, Ferrara JL, et al. EBMT-NIH-CIBMTR task force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant. 2018;53(11):1401–1415.
  • Azarbal A, LeWinter MM. Pericardial effusion. Cardiol Clin. 2017;35(4):515–524.
  • Yanagisawa R, Ishii E, Motoki N, et al. Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation. Transpl Int. 2015;28(5):565–574.
  • Dean RM, Fry T, Mackall C, et al. Association of serum interleukin-7 levels with the development of acute graft-versus-host disease. J Clin Oncol. 2008;26(35):5735–5741.
  • Lee CC, Chang HH, Lu MY, et al. The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan. Ann Hematol. 2019;98(3):745–752.
  • Yang CL, Wang XD, Zhou XH, et al. Clinical characteristics and risk factors of pericardial effusion after hematopoietic stem cell transplantation in children with thalassemia major. Chin J Pediatr. 2022;60(4):323–328.
  • Xuan L, Huang F, Fan Z, et al. Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies. J Hematol Oncol. 2012;5:46.